Injectable Anticoagulants Industry Research Report 2023
Highlights
The global Injectable Anticoagulants market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Injectable Anticoagulants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Injectable Anticoagulants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Injectable Anticoagulants include Sanofi, Genentech (Roche), Boehringer Ingelheim, Aspen, Pfizer, Hepalink, King-friend, CSBIO and Amphastar Pharmaceuticals, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Injectable Anticoagulants in VTE is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, LMWH, which accounted for % of the global market of Injectable Anticoagulants in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injectable Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anticoagulants.
The Injectable Anticoagulants market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Injectable Anticoagulants market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Anticoagulants companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Injectable Anticoagulants type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Injectable Anticoagulants are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Injectable Anticoagulants segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Injectable Anticoagulants market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Injectable Anticoagulants market.
Injectable Anticoagulants Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Injectable Anticoagulants market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Injectable Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Injectable Anticoagulants industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Anticoagulants.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Injectable Anticoagulants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global Injectable Anticoagulants market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Injectable Anticoagulants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Injectable Anticoagulants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Injectable Anticoagulants include Sanofi, Genentech (Roche), Boehringer Ingelheim, Aspen, Pfizer, Hepalink, King-friend, CSBIO and Amphastar Pharmaceuticals, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Injectable Anticoagulants in VTE is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, LMWH, which accounted for % of the global market of Injectable Anticoagulants in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injectable Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anticoagulants.
The Injectable Anticoagulants market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Injectable Anticoagulants market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Anticoagulants companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi
- Genentech (Roche)
- Boehringer Ingelheim
- Aspen
- Pfizer
- Hepalink
- King-friend
- CSBIO
- Amphastar Pharmaceuticals
Global markets are presented by Injectable Anticoagulants type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Injectable Anticoagulants are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Injectable Anticoagulants segment by Type
- LMWH
- Unfractionated Heparin
- Fibrinolytics
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Injectable Anticoagulants market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Injectable Anticoagulants market.
Injectable Anticoagulants Segment by Application
- VTE
- ACS/MI
- AF
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Injectable Anticoagulants market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Injectable Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Injectable Anticoagulants industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Anticoagulants.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Injectable Anticoagulants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Injectable Anticoagulants by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 LMWH
1.2.3 Unfractionated Heparin
1.2.4 Fibrinolytics
1.2.5 Others
2.3 Injectable Anticoagulants by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 VTE
2.3.3 ACS/MI
2.3.4 AF
2.3.5 Others
2.4 Assumptions and Limitations
3 INJECTABLE ANTICOAGULANTS BREAKDOWN DATA BY TYPE
3.1 Global Injectable Anticoagulants Historic Market Size by Type (2018-2023)
3.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2023-2028)
4 INJECTABLE ANTICOAGULANTS BREAKDOWN DATA BY APPLICATION
4.1 Global Injectable Anticoagulants Historic Market Size by Application (2018-2023)
4.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Injectable Anticoagulants Market Perspective (2018-2029)
5.2 Global Injectable Anticoagulants Growth Trends by Region
5.2.1 Global Injectable Anticoagulants Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Injectable Anticoagulants Historic Market Size by Region (2018-2023)
5.2.3 Injectable Anticoagulants Forecasted Market Size by Region (2024-2029)
5.3 Injectable Anticoagulants Market Dynamics
5.3.1 Injectable Anticoagulants Industry Trends
5.3.2 Injectable Anticoagulants Market Drivers
5.3.3 Injectable Anticoagulants Market Challenges
5.3.4 Injectable Anticoagulants Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Injectable Anticoagulants Players by Revenue
6.1.1 Global Top Injectable Anticoagulants Players by Revenue (2018-2023)
6.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2018-2023)
6.2 Global Injectable Anticoagulants Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Injectable Anticoagulants Head office and Area Served
6.4 Global Injectable Anticoagulants Players, Product Type & Application
6.5 Global Injectable Anticoagulants Players, Date of Enter into This Industry
6.6 Global Injectable Anticoagulants Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Injectable Anticoagulants Market Size (2018-2029)
7.2 North America Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Injectable Anticoagulants Market Size by Country (2018-2023)
7.4 North America Injectable Anticoagulants Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Injectable Anticoagulants Market Size (2018-2029)
8.2 Europe Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Injectable Anticoagulants Market Size by Country (2018-2023)
8.4 Europe Injectable Anticoagulants Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Injectable Anticoagulants Market Size (2018-2029)
9.2 Asia-Pacific Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Injectable Anticoagulants Market Size by Country (2018-2023)
9.4 Asia-Pacific Injectable Anticoagulants Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Injectable Anticoagulants Market Size (2018-2029)
10.2 Latin America Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Injectable Anticoagulants Market Size by Country (2018-2023)
10.4 Latin America Injectable Anticoagulants Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Injectable Anticoagulants Market Size (2018-2029)
11.2 Middle East & Africa Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Injectable Anticoagulants Market Size by Country (2018-2023)
11.4 Middle East & Africa Injectable Anticoagulants Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injectable Anticoagulants Introduction
11.1.4 Sanofi Revenue in Injectable Anticoagulants Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Detail
11.2.2 Genentech (Roche) Business Overview
11.2.3 Genentech (Roche) Injectable Anticoagulants Introduction
11.2.4 Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022)
11.2.5 Genentech (Roche) Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction
11.3.4 Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Aspen
11.4.1 Aspen Company Detail
11.4.2 Aspen Business Overview
11.4.3 Aspen Injectable Anticoagulants Introduction
11.4.4 Aspen Revenue in Injectable Anticoagulants Business (2017-2022)
11.4.5 Aspen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Injectable Anticoagulants Introduction
11.5.4 Pfizer Revenue in Injectable Anticoagulants Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Hepalink
11.6.1 Hepalink Company Detail
11.6.2 Hepalink Business Overview
11.6.3 Hepalink Injectable Anticoagulants Introduction
11.6.4 Hepalink Revenue in Injectable Anticoagulants Business (2017-2022)
11.6.5 Hepalink Recent Development
11.7 King-friend
11.7.1 King-friend Company Detail
11.7.2 King-friend Business Overview
11.7.3 King-friend Injectable Anticoagulants Introduction
11.7.4 King-friend Revenue in Injectable Anticoagulants Business (2017-2022)
11.7.5 King-friend Recent Development
11.8 CSBIO
11.8.1 CSBIO Company Detail
11.8.2 CSBIO Business Overview
11.8.3 CSBIO Injectable Anticoagulants Introduction
11.8.4 CSBIO Revenue in Injectable Anticoagulants Business (2017-2022)
11.8.5 CSBIO Recent Development
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Detail
11.9.2 Amphastar Pharmaceuticals Business Overview
11.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Introduction
11.9.4 Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022)
11.9.5 Amphastar Pharmaceuticals Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Injectable Anticoagulants by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 LMWH
1.2.3 Unfractionated Heparin
1.2.4 Fibrinolytics
1.2.5 Others
2.3 Injectable Anticoagulants by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 VTE
2.3.3 ACS/MI
2.3.4 AF
2.3.5 Others
2.4 Assumptions and Limitations
3 INJECTABLE ANTICOAGULANTS BREAKDOWN DATA BY TYPE
3.1 Global Injectable Anticoagulants Historic Market Size by Type (2018-2023)
3.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2023-2028)
4 INJECTABLE ANTICOAGULANTS BREAKDOWN DATA BY APPLICATION
4.1 Global Injectable Anticoagulants Historic Market Size by Application (2018-2023)
4.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Injectable Anticoagulants Market Perspective (2018-2029)
5.2 Global Injectable Anticoagulants Growth Trends by Region
5.2.1 Global Injectable Anticoagulants Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Injectable Anticoagulants Historic Market Size by Region (2018-2023)
5.2.3 Injectable Anticoagulants Forecasted Market Size by Region (2024-2029)
5.3 Injectable Anticoagulants Market Dynamics
5.3.1 Injectable Anticoagulants Industry Trends
5.3.2 Injectable Anticoagulants Market Drivers
5.3.3 Injectable Anticoagulants Market Challenges
5.3.4 Injectable Anticoagulants Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Injectable Anticoagulants Players by Revenue
6.1.1 Global Top Injectable Anticoagulants Players by Revenue (2018-2023)
6.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2018-2023)
6.2 Global Injectable Anticoagulants Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Injectable Anticoagulants Head office and Area Served
6.4 Global Injectable Anticoagulants Players, Product Type & Application
6.5 Global Injectable Anticoagulants Players, Date of Enter into This Industry
6.6 Global Injectable Anticoagulants Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Injectable Anticoagulants Market Size (2018-2029)
7.2 North America Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Injectable Anticoagulants Market Size by Country (2018-2023)
7.4 North America Injectable Anticoagulants Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Injectable Anticoagulants Market Size (2018-2029)
8.2 Europe Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Injectable Anticoagulants Market Size by Country (2018-2023)
8.4 Europe Injectable Anticoagulants Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Injectable Anticoagulants Market Size (2018-2029)
9.2 Asia-Pacific Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Injectable Anticoagulants Market Size by Country (2018-2023)
9.4 Asia-Pacific Injectable Anticoagulants Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Injectable Anticoagulants Market Size (2018-2029)
10.2 Latin America Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Injectable Anticoagulants Market Size by Country (2018-2023)
10.4 Latin America Injectable Anticoagulants Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Injectable Anticoagulants Market Size (2018-2029)
11.2 Middle East & Africa Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Injectable Anticoagulants Market Size by Country (2018-2023)
11.4 Middle East & Africa Injectable Anticoagulants Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injectable Anticoagulants Introduction
11.1.4 Sanofi Revenue in Injectable Anticoagulants Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Detail
11.2.2 Genentech (Roche) Business Overview
11.2.3 Genentech (Roche) Injectable Anticoagulants Introduction
11.2.4 Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022)
11.2.5 Genentech (Roche) Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction
11.3.4 Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Aspen
11.4.1 Aspen Company Detail
11.4.2 Aspen Business Overview
11.4.3 Aspen Injectable Anticoagulants Introduction
11.4.4 Aspen Revenue in Injectable Anticoagulants Business (2017-2022)
11.4.5 Aspen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Injectable Anticoagulants Introduction
11.5.4 Pfizer Revenue in Injectable Anticoagulants Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Hepalink
11.6.1 Hepalink Company Detail
11.6.2 Hepalink Business Overview
11.6.3 Hepalink Injectable Anticoagulants Introduction
11.6.4 Hepalink Revenue in Injectable Anticoagulants Business (2017-2022)
11.6.5 Hepalink Recent Development
11.7 King-friend
11.7.1 King-friend Company Detail
11.7.2 King-friend Business Overview
11.7.3 King-friend Injectable Anticoagulants Introduction
11.7.4 King-friend Revenue in Injectable Anticoagulants Business (2017-2022)
11.7.5 King-friend Recent Development
11.8 CSBIO
11.8.1 CSBIO Company Detail
11.8.2 CSBIO Business Overview
11.8.3 CSBIO Injectable Anticoagulants Introduction
11.8.4 CSBIO Revenue in Injectable Anticoagulants Business (2017-2022)
11.8.5 CSBIO Recent Development
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Detail
11.9.2 Amphastar Pharmaceuticals Business Overview
11.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Introduction
11.9.4 Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022)
11.9.5 Amphastar Pharmaceuticals Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Injectable Anticoagulants Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Injectable Anticoagulants Revenue Market Share by Type (2018-2023)
Table 7. Global Injectable Anticoagulants Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Injectable Anticoagulants Revenue Market Share by Type (2024-2029)
Table 9. Global Injectable Anticoagulants Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Injectable Anticoagulants Revenue Market Share by Application (2018-2023)
Table 11. Global Injectable Anticoagulants Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Injectable Anticoagulants Revenue Market Share by Application (2024-2029)
Table 13. Global Injectable Anticoagulants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Injectable Anticoagulants Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Injectable Anticoagulants Market Share by Region (2018-2023)
Table 16. Global Injectable Anticoagulants Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Injectable Anticoagulants Market Share by Region (2024-2029)
Table 18. Injectable Anticoagulants Market Trends
Table 19. Injectable Anticoagulants Market Drivers
Table 20. Injectable Anticoagulants Market Challenges
Table 21. Injectable Anticoagulants Market Restraints
Table 22. Global Top Injectable Anticoagulants Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Injectable Anticoagulants Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Injectable Anticoagulants Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Injectable Anticoagulants, Headquarters and Area Served
Table 26. Global Injectable Anticoagulants Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Injectable Anticoagulants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 45. Sanofi Company Detail
Table 46. Sanofi Business Overview
Table 47. Sanofi Injectable Anticoagulants Product
Table 48. Sanofi Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 49. Sanofi Recent Development
Table 50. Genentech (Roche) Company Detail
Table 51. Genentech (Roche) Business Overview
Table 52. Genentech (Roche) Injectable Anticoagulants Product
Table 53. Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 54. Genentech (Roche) Recent Development
Table 55. Boehringer Ingelheim Company Detail
Table 56. Boehringer Ingelheim Business Overview
Table 57. Boehringer Ingelheim Injectable Anticoagulants Product
Table 58. Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 59. Boehringer Ingelheim Recent Development
Table 60. Aspen Company Detail
Table 61. Aspen Business Overview
Table 62. Aspen Injectable Anticoagulants Product
Table 63. Aspen Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 64. Aspen Recent Development
Table 65. Pfizer Company Detail
Table 66. Pfizer Business Overview
Table 67. Pfizer Injectable Anticoagulants Product
Table 68. Pfizer Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Hepalink Company Detail
Table 71. Hepalink Business Overview
Table 72. Hepalink Injectable Anticoagulants Product
Table 73. Hepalink Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 74. Hepalink Recent Development
Table 75. King-friend Company Detail
Table 76. King-friend Business Overview
Table 77. King-friend Injectable Anticoagulants Product
Table 78. King-friend Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 79. King-friend Recent Development
Table 80. CSBIO Company Detail
Table 81. CSBIO Business Overview
Table 82. CSBIO Injectable Anticoagulants Product
Table 83. CSBIO Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 84. CSBIO Recent Development
Table 85. Amphastar Pharmaceuticals Company Detail
Table 86. Amphastar Pharmaceuticals Business Overview
Table 87. Amphastar Pharmaceuticals Injectable Anticoagulants Product
Table 88. Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 89. Amphastar Pharmaceuticals Recent Development
Table 90. Sanofi Company Information
Table 91. Sanofi Business Overview
Table 92. Sanofi Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 93. Sanofi Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 94. Sanofi Recent Development
Table 95. Genentech (Roche) Company Information
Table 96. Genentech (Roche) Business Overview
Table 97. Genentech (Roche) Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 98. Genentech (Roche) Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 99. Genentech (Roche) Recent Development
Table 100. Boehringer Ingelheim Company Information
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 103. Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 104. Boehringer Ingelheim Recent Development
Table 105. Aspen Company Information
Table 106. Aspen Business Overview
Table 107. Aspen Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 108. Aspen Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 109. Aspen Recent Development
Table 110. Pfizer Company Information
Table 111. Pfizer Business Overview
Table 112. Pfizer Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 113. Pfizer Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 114. Pfizer Recent Development
Table 115. Hepalink Company Information
Table 116. Hepalink Business Overview
Table 117. Hepalink Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 118. Hepalink Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 119. Hepalink Recent Development
Table 120. King-friend Company Information
Table 121. King-friend Business Overview
Table 122. King-friend Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 123. King-friend Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 124. King-friend Recent Development
Table 125. CSBIO Company Information
Table 126. CSBIO Business Overview
Table 127. CSBIO Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 128. CSBIO Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 129. CSBIO Recent Development
Table 130. Amphastar Pharmaceuticals Company Information
Table 131. Amphastar Pharmaceuticals Business Overview
Table 132. Amphastar Pharmaceuticals Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 133. Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 134. Amphastar Pharmaceuticals Recent Development
Table 135. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Injectable Anticoagulants Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Injectable Anticoagulants Revenue Market Share by Type (2018-2023)
Table 7. Global Injectable Anticoagulants Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Injectable Anticoagulants Revenue Market Share by Type (2024-2029)
Table 9. Global Injectable Anticoagulants Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Injectable Anticoagulants Revenue Market Share by Application (2018-2023)
Table 11. Global Injectable Anticoagulants Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Injectable Anticoagulants Revenue Market Share by Application (2024-2029)
Table 13. Global Injectable Anticoagulants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Injectable Anticoagulants Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Injectable Anticoagulants Market Share by Region (2018-2023)
Table 16. Global Injectable Anticoagulants Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Injectable Anticoagulants Market Share by Region (2024-2029)
Table 18. Injectable Anticoagulants Market Trends
Table 19. Injectable Anticoagulants Market Drivers
Table 20. Injectable Anticoagulants Market Challenges
Table 21. Injectable Anticoagulants Market Restraints
Table 22. Global Top Injectable Anticoagulants Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Injectable Anticoagulants Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Injectable Anticoagulants Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Injectable Anticoagulants, Headquarters and Area Served
Table 26. Global Injectable Anticoagulants Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Injectable Anticoagulants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Injectable Anticoagulants Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Injectable Anticoagulants Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Injectable Anticoagulants Market Size by Country (2024-2029) & (US$ Million)
Table 45. Sanofi Company Detail
Table 46. Sanofi Business Overview
Table 47. Sanofi Injectable Anticoagulants Product
Table 48. Sanofi Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 49. Sanofi Recent Development
Table 50. Genentech (Roche) Company Detail
Table 51. Genentech (Roche) Business Overview
Table 52. Genentech (Roche) Injectable Anticoagulants Product
Table 53. Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 54. Genentech (Roche) Recent Development
Table 55. Boehringer Ingelheim Company Detail
Table 56. Boehringer Ingelheim Business Overview
Table 57. Boehringer Ingelheim Injectable Anticoagulants Product
Table 58. Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 59. Boehringer Ingelheim Recent Development
Table 60. Aspen Company Detail
Table 61. Aspen Business Overview
Table 62. Aspen Injectable Anticoagulants Product
Table 63. Aspen Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 64. Aspen Recent Development
Table 65. Pfizer Company Detail
Table 66. Pfizer Business Overview
Table 67. Pfizer Injectable Anticoagulants Product
Table 68. Pfizer Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Hepalink Company Detail
Table 71. Hepalink Business Overview
Table 72. Hepalink Injectable Anticoagulants Product
Table 73. Hepalink Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 74. Hepalink Recent Development
Table 75. King-friend Company Detail
Table 76. King-friend Business Overview
Table 77. King-friend Injectable Anticoagulants Product
Table 78. King-friend Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 79. King-friend Recent Development
Table 80. CSBIO Company Detail
Table 81. CSBIO Business Overview
Table 82. CSBIO Injectable Anticoagulants Product
Table 83. CSBIO Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 84. CSBIO Recent Development
Table 85. Amphastar Pharmaceuticals Company Detail
Table 86. Amphastar Pharmaceuticals Business Overview
Table 87. Amphastar Pharmaceuticals Injectable Anticoagulants Product
Table 88. Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 89. Amphastar Pharmaceuticals Recent Development
Table 90. Sanofi Company Information
Table 91. Sanofi Business Overview
Table 92. Sanofi Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 93. Sanofi Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 94. Sanofi Recent Development
Table 95. Genentech (Roche) Company Information
Table 96. Genentech (Roche) Business Overview
Table 97. Genentech (Roche) Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 98. Genentech (Roche) Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 99. Genentech (Roche) Recent Development
Table 100. Boehringer Ingelheim Company Information
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 103. Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 104. Boehringer Ingelheim Recent Development
Table 105. Aspen Company Information
Table 106. Aspen Business Overview
Table 107. Aspen Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 108. Aspen Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 109. Aspen Recent Development
Table 110. Pfizer Company Information
Table 111. Pfizer Business Overview
Table 112. Pfizer Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 113. Pfizer Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 114. Pfizer Recent Development
Table 115. Hepalink Company Information
Table 116. Hepalink Business Overview
Table 117. Hepalink Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 118. Hepalink Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 119. Hepalink Recent Development
Table 120. King-friend Company Information
Table 121. King-friend Business Overview
Table 122. King-friend Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 123. King-friend Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 124. King-friend Recent Development
Table 125. CSBIO Company Information
Table 126. CSBIO Business Overview
Table 127. CSBIO Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 128. CSBIO Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 129. CSBIO Recent Development
Table 130. Amphastar Pharmaceuticals Company Information
Table 131. Amphastar Pharmaceuticals Business Overview
Table 132. Amphastar Pharmaceuticals Injectable Anticoagulants Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million)
Table 133. Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2018-2023) & (US$ Million) Portfolio
Table 134. Amphastar Pharmaceuticals Recent Development
Table 135. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Injectable Anticoagulants Product Picture
Figure 5. Global Injectable Anticoagulants Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Injectable Anticoagulants Market Share by Type: 2022 VS 2029
Figure 7. LMWH Product Picture
Figure 8. Unfractionated Heparin Product Picture
Figure 9. Fibrinolytics Product Picture
Figure 10. Others Product Picture
Figure 11. Global Injectable Anticoagulants Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Injectable Anticoagulants Market Share by Application: 2022 VS 2029
Figure 13. VTE Product Picture
Figure 14. ACS/MI Product Picture
Figure 15. AF Product Picture
Figure 16. Others Product Picture
Figure 17. Global Injectable Anticoagulants Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Injectable Anticoagulants Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Injectable Anticoagulants Market Share by Region: 2022 VS 2029
Figure 20. Global Injectable Anticoagulants Market Share by Players in 2022
Figure 21. Global Injectable Anticoagulants Players, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Injectable Anticoagulants Players Market Share by Revenue in 2022
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. North America Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 26. United States Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 30. Germany Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 38. China Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 46. Mexico Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 50. Turkey Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. UAE Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Sanofi Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 54. Genentech (Roche) Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 56. Aspen Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 58. Hepalink Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 59. King-friend Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 60. CSBIO Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 61. Amphastar Pharmaceuticals Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Injectable Anticoagulants Product Picture
Figure 5. Global Injectable Anticoagulants Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Injectable Anticoagulants Market Share by Type: 2022 VS 2029
Figure 7. LMWH Product Picture
Figure 8. Unfractionated Heparin Product Picture
Figure 9. Fibrinolytics Product Picture
Figure 10. Others Product Picture
Figure 11. Global Injectable Anticoagulants Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Injectable Anticoagulants Market Share by Application: 2022 VS 2029
Figure 13. VTE Product Picture
Figure 14. ACS/MI Product Picture
Figure 15. AF Product Picture
Figure 16. Others Product Picture
Figure 17. Global Injectable Anticoagulants Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Injectable Anticoagulants Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Injectable Anticoagulants Market Share by Region: 2022 VS 2029
Figure 20. Global Injectable Anticoagulants Market Share by Players in 2022
Figure 21. Global Injectable Anticoagulants Players, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Injectable Anticoagulants Players Market Share by Revenue in 2022
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. North America Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 26. United States Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 30. Germany Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 38. China Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 46. Mexico Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Injectable Anticoagulants Market Share by Country (2018-2029)
Figure 50. Turkey Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. UAE Injectable Anticoagulants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Sanofi Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 54. Genentech (Roche) Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 56. Aspen Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 58. Hepalink Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 59. King-friend Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 60. CSBIO Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
Figure 61. Amphastar Pharmaceuticals Revenue Growth Rate in Injectable Anticoagulants Business (2018-2023)
